{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:44:32Z","timestamp":1764585872260,"version":"3.46.0"},"reference-count":26,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,10,12]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Tubulointerstitial nephritis and uveitis (TINU) syndrome is characterised by bilateral anterior uveitis and acute kidney injury secondary to interstitial nephritis. Corticosteroids remain the cornerstone of therapy. There is little data around the use of steroid-sparing agents.<\/jats:p>\n                  <jats:p>We present a female in her sixth decade of life of Caucasian ethnicity who presented with acute kidney failure requiring dialysis from TINU. Systemic corticosteroids were commenced; however, she developed a cushingoid appearance, proximal myopathy and hyperglycaemia. Mycophenolate mofetil was initiated as a steroid-sparing agent with significant improvement in kidney function. She remains well 2.5 years later. Incidentally, she was noted to have a distant history of vulval sarcoidosis without any other evidence of active disease on imaging and a normal serum angiotensin-converting enzyme.<\/jats:p>\n                  <jats:p>This case demonstrates successful long-term outcomes of mycophenolate in the management of TINU.<\/jats:p>","DOI":"10.1136\/bcr-2025-266877","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T04:10:15Z","timestamp":1762402215000},"page":"e266877","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Successful long-term treatment of tubulointerstitial nephritis and uveitis with mycophenolate"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3128-4865","authenticated-orcid":false,"given":"Liam","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Nephrology, Queensland Health, Brisbane, Queensland, Australia"},{"name":"The University of Queensland Faculty of Medicine, Herston, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-0060","authenticated-orcid":false,"given":"Shaun","family":"Chandler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Queensland Health, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prianka","family":"Puri","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Queensland Health, Brisbane, Queensland, Australia"},{"name":"The University of Queensland Faculty of Medicine, Herston, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Hepburn","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Queensland Health, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2025120102402324000_18.11.e266877.1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(75)90390-3"},{"key":"2025120102402324000_18.11.e266877.2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01095961"},{"key":"2025120102402324000_18.11.e266877.3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13023-017-0677-2","article-title":"Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors","volume":"12","author":"Okafor","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2025120102402324000_18.11.e266877.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00261-2"},{"key":"2025120102402324000_18.11.e266877.5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40620-022-01478-8","article-title":"Renal outcomes in tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review and meta-analysis","volume":"36","author":"Southgate","year":"2023","journal-title":"J Nephrol"},{"key":"2025120102402324000_18.11.e266877.6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12016-023-08963-3","article-title":"Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity","volume":"65","author":"Bhat","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025120102402324000_18.11.e266877.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc0810841"},{"key":"2025120102402324000_18.11.e266877.8","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells"},{"key":"2025120102402324000_18.11.e266877.9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40620-022-01369-y","article-title":"Renal sarcoidosis","volume":"36","author":"Calatroni","year":"2023","journal-title":"J Nephrol"},{"key":"2025120102402324000_18.11.e266877.10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5414\/CNP96S02","article-title":"Characteristics of renal sarcoidosis and tubulointerstitial nephritis and uveitis syndrome in Slovenia: An analysis of the national renal biopsy registry and patient datasets in the last decade","volume":"96","author":"Frelih","year":"2021","journal-title":"Clin Nephrol"},{"key":"2025120102402324000_18.11.e266877.11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-016-3394-5","article-title":"Tubulointerstitial nephritis: diagnosis, treatment, and monitoring","volume":"32","author":"Joyce","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"2025120102402324000_18.11.e266877.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1698-4"},{"key":"2025120102402324000_18.11.e266877.13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/ICU.0000000000000421","article-title":"Tubulointerstitial nephritis and uveitis","volume":"28","author":"Pakzad-Vaezi","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"2025120102402324000_18.11.e266877.14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003964","article-title":"Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: A national retrospective strobe-compliant study","volume":"95","author":"Legendre","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025120102402324000_18.11.e266877.15","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020300","article-title":"A Comprehensive Review of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome","volume":"13","author":"Bograd","year":"2025","journal-title":"Biomedicines"},{"key":"2025120102402324000_18.11.e266877.16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01711105"},{"key":"2025120102402324000_18.11.e266877.17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ajo.2013.12.006","article-title":"HLA-DR, DQ class II DNA typing in pediatric panuveitis and tubulointerstitial nephritis and uveitis","volume":"157","author":"Reddy","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"2025120102402324000_18.11.e266877.18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3341\/kjo.2020.0029","article-title":"Long-term Treatment Outcome of Tubulo-interstitial Nephritis and Uveitis Syndrome Associated Panuveitis with Steroid and Mycophenolate Mofetil","volume":"34","author":"Leung","year":"2020","journal-title":"Korean J Ophthalmol"},{"key":"2025120102402324000_18.11.e266877.19","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn006"},{"key":"2025120102402324000_18.11.e266877.20","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1568240"},{"key":"2025120102402324000_18.11.e266877.21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaapos.2018.02.004","article-title":"Tubulointerstitial nephritis and uveitis (TINU) with granulomatosis: a novel report of simultaneous TINU and sarcoidosis in a pediatric patient","volume":"22","author":"Dawson","year":"2018","journal-title":"J AAPOS"},{"key":"2025120102402324000_18.11.e266877.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-88713-x","article-title":"Global burden of vaccine-associated kidney injury using an international pharmacovigilance database","volume":"15","author":"Hwang","year":"2025","journal-title":"Sci Rep"},{"key":"2025120102402324000_18.11.e266877.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2023.101869","article-title":"Tubulointerstitial nephritis and uveitis syndrome (TINU) following COVID-19 vaccination","volume":"31","author":"Chen","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025120102402324000_18.11.e266877.24","doi-asserted-by":"crossref","first-page":"152278","DOI":"10.1016\/j.semarthrit.2023.152278","article-title":"IgG4-related uveitis. A French cohort and literature review","volume":"64","author":"Stuchfield-Denby","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"2025120102402324000_18.11.e266877.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2012.07.004"},{"key":"2025120102402324000_18.11.e266877.26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.ajkd.2011.12.011","article-title":"TINU (tubulointerstitial nephritis and uveitis) syndrome is not usually associated with IgG4 sclerosing disease","volume":"59","author":"Houghton","year":"2012","journal-title":"Am J Kidney Dis"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-266877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:40:32Z","timestamp":1764585632000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-266877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bcr-2025-266877"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-266877","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}